Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 20 Nov 23 EFFECT Notice of effectiveness
- 9 Nov 23 POS AM Prospectus update (post-effective amendment)
- 25 Nov 22 424B3 Prospectus supplement
- 10 Nov 22 424B3 Prospectus supplement
- 11 Aug 22 424B3 Prospectus supplement
- 13 May 22 424B3 Prospectus supplement
- 29 Mar 22 EFFECT Notice of effectiveness
- 23 Mar 22 POS AM Prospectus update (post-effective amendment)
- 10 Jan 22 424B3 Prospectus supplement
- 27 Dec 21 EFFECT Notice of effectiveness
- 23 Dec 21 424B3 Prospectus supplement
-
21 Dec 21 S-1 IPO registration
EQRX similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the use in the prospectus constituting a part of this Registration Statement on Form S-1 our report dated April 8, 2021 relating to the financial statements of CM Life Sciences III Inc. which is contained in that prospectus, and to the references to our Firm under the caption “Experts” in the prospectus.
/s/ WithumSmith+Brown, PC | |
New York, New York | |
December 20, 2021 |